Dispensary Manufacturing Contests Media Kit

Clinical data presented at AAOS 2021 Annual Meeting shows higher complication rates and adverse events when cannabis is used prior to orthopaedic surgeries

Chosen by Staff Editors on 31-AUG-21

According to three studies presented at the 2021 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS), using cannabis before total knee arthroplasty (TKA) and total hip arthroplasty (THA) can lead to increased complications, longer hospital stays, higher rates of adverse events, increased readmissions, and higher costs. These studies point to the need for further research and will help orthopaedic surgeons educate and counsel patients prior to surgery.

Cannabis use in the United States

As more states in the U.S. legalize cannabis use, there has been an increase in usage for both medicinal and recreation purposes, including an increase among the older populations. From 2002 to 2014, marijuana consumption increased 48% in adults ages 45 to 54 and 455% in adults ages 55 to 64. However, the impact of cannabis use on the outcomes of TKA and THA has not been well studied.

Preoperative marijuana and TKA: Outcomes at 90 days and one year

Employing a large insurance database, researchers (led by Chukwuweike Gwam, MD, orthopaedic surgery resident, Wake Forest Baptist Medical Center in Winston_Salem, N.C.) retrospectively reviewed 3,308 TKA patients between 2010 and 2018 to assess 90_day and one_year outcomes (opioid consumption, readmissions, revisions, and complications) in a matched cohort of patients who consumed cannabis preoperatively and those who did not. The findings noted:

Dislocation rates were significantly higher among marijuana users than nonusers at both 90 days and one year.

Opioid consumption and revision rates were similar or not significantly different between the groups at 90 days.

Revisions and all complications were similar in occurrence at 90 days and year.

The association of cannabis use disorder and perioperative complications following TKA

Investigators (led by Rushabh Vakharia, MD, research fellow, Maimonides Medical Center, Brooklyn, N.Y.) studied the association of cannabis use disorder (CUD), which is a problematic pattern of using cannabis in progressively larger amounts over period of time, on outcomes following primary TKA. Using a private database, 55,553 patients were enrolled in the CUD (n = 9,260) and case_matched populations (n = 46,293), and investigators performed a retrospective query from Jan. 1, 2008, to March 31, 2018. The study demonstrated:

CUD patients had significantly longer in_hospital length of stay (3.61 vs. 2.07 days) compared to their counterparts. Over the course of the study period, in_hospital length of stay (LOS) for CUD patients increased from an average of 2.93 days in 2010 to 3.93 days in 2018.

Patients with CUD had significantly higher likelihood of developing medical complications within 90 days (28.08% vs. 12.50%), including pneumonia, respiratory failures, myocardial infarctions, cerebrovascular accidents, and acute kidney injuries, in addition to other medical complications.

CUD was also associated with higher rates of prostheses_related complications compared to controls (9.63% vs. 5.16%).

Patients with CUD had significantly higher day of surgery costs ($24,292.15 vs. $20,616.40) and total global 90_day episode of care costs ($29,025.34 vs. $24,258.17).

A matched_control analysis on the effects of CUD on in_hospital LOS, complications and costs following primary THA

The study (led by Asad Ashraf, MD, orthopaedic surgery resident, Maimonides Medical Center, Brooklyn, N.Y.) was designed to determine whether CUD patients undergoing primary THA have higher rates of in_hospital LOS, complications, and costs of care. Investigators compiled a retrospective query from Jan. 1, 2008, to Dec. 31, 2018. The query compiled from a private payor database produced 44,154 patients who underwent primary THA. the patients were then divided into those with CUD (n = 7,361) and without CUD (n = 36,793). The researchers found:

CUD patients undergoing primary THA had significantly longer in_hospital LOS (4 vs. 3 days) compared to the control group.

CUD patients experienced a higher frequency of adverse events (11.23% vs. 4.82%), including higher rates of pneumonia, respiratory failure, cerebrovascular accidents, urinary tract infections, and acute renal failure.

CUD patients had significantly higher total global 90_day costs of care ($24,585.96 vs. $23,724.93).

About the AAOS

With more than 39,000 members, the American Academy of Orthopaedic Surgeons is the world's largest medical association of musculoskeletal specialists. The AAOS is the trusted leader in advancing musculoskeletal health. It provides the highest quality, most comprehensive education to help orthopaedic surgeons and allied health professionals at every career level best treat patients in their daily practices. The AAOS is the source for information on bone and joint conditions, treatments, and related musculoskeletal health care issues, and it leads the health care discussion on advancing quality.

Clinical data presented at AAOS 2021 Annual Meeting shows higher complication rates and adverse events when cannabis is used prior to orthopaedic surgeries

Related URL:

This article is from the Testing Lab basket.
(Important there are many baskets: Basketball, Basketcase, Basket the Magnificant, Utility Basket, A Woven Basket ... in our case a basket is just a basket. Go Figure!)

Next Story

Support Our Sponsors


RED ALERT! Privacy Policy: WE DO NOT TRACK. Frankly, we do not give a hoot. What does that mean? Well, when you look for a Marijuana Dispensary you have to scroll to your own city, instead of a blue dot on a map. Only native html ads are on this site. No network ads. No cookie bunnies. None. If you really miss Big Brother helping you browse the web, best you not be here. I know. stoners do not like working? Ha! So, again, we have a 100% no tracking policy. Questions? Email The content herein, unless otherwise known to be public domain, are Copyright 2018-2021 The Daily Network LLC. All websites are published in United States of America and are solely subject to US law and governed by Fair Use principals for news reporting and research purposes. All Goverment sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by The Daily Network LLC on any Web page published or hosted by The Daily Network LLC. Dispensary Manufacturing Contests Media Kit